Background Coronavirus disease 2019 (COVID-19) has become a global pandemic,
affecting millions of people. However, the relationship between COVID-19 and acute …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
neurological symptoms increasingly moved into the focus of interest. In this prospective …

Anosmia is one of the most prevalent symptoms of SARS-CoV-2 infection during the COVID-
19 pandemic. However, the cellular mechanism behind the sudden loss of smell has not yet …

Central and peripheral nervous system involvement during acute COVID-19 is well known.
Although many patients report some subjective symptoms months after the infection, the …

Background and purpose Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)
infection predisposes patients to arterial and venous thrombosis. This study aimed to …

Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Background Clinical investigations have argued for long-term neurological manifestations in
both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term …

Abstract Background In December 2019, unexplained cases of pneumonia emerged in
Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On …

Background COVID-19 has affected social interaction and healthcare worldwide. Methods
We examined changes in presentations and referrals to the primary provider of mental …